INSM vs VRTX: Which Stock is Better?
Side-by-side comparison of Insmed Inc and Vertex Pharmaceuticals Inc in 2026
INSM
Insmed Inc
$146.74
VRTX
Vertex Pharmaceuticals Inc
$441.70
Key Metrics Comparison
| Metric | INSM | VRTX | Winner |
|---|---|---|---|
| Market Cap | $31.67B | $113.01B | VRTX |
| P/E Ratio | N/A | 28.98 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | 1.5% | 0.1% | INSM |
| Gross Margin | 79.7% | 53.7% | INSM |
Analyze INSM
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INSM or VRTX a better investment?
Comparing INSM and VRTX: Insmed Inc has a market cap of $31.67B while Vertex Pharmaceuticals Inc has $113.01B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INSM and VRTX?
INSM (Insmed Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INSM or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INSM or VRTX?
INSM has higher revenue growth at 1.5% vs 0.1% for VRTX.
Which company is more profitable: INSM or VRTX?
Insmed Inc (INSM) has higher gross margins at 79.7% compared to 53.7% for VRTX.
Which is the larger company: INSM or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.01B compared to $31.67B for INSM.
Should I buy INSM or VRTX in 2026?
Both INSM and VRTX have investment merit. INSM trades at $146.74 while VRTX trades at $441.70. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INSM and VRTX stock?
Key differences: Market Cap ($31.67B vs $113.01B), P/E Ratio (N/A vs 29.0x), Revenue Growth (1.5% vs 0.1%), Gross Margin (79.7% vs 53.7%).